The WACC of NexgenRx Inc (NXG.V) is 6.7%.
Range | Selected | |
Cost of equity | 5.7% - 7.9% | 6.8% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 5.0% - 5.0% | 5% |
WACC | 5.7% - 7.8% | 6.7% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.37 | 0.5 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.7% | 7.9% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.03 | 0.03 |
Cost of debt | 5.0% | 5.0% |
After-tax WACC | 5.7% | 7.8% |
Selected WACC | 6.7% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
NXG.V | NexgenRx Inc | 0.03 | 1.06 | 1.04 |
AOREF | American Overseas Group Ltd | 0.74 | 0.15 | 0.1 |
BRP | BRP Group Inc | 0.34 | 0.95 | 0.76 |
CUII | China United Insurance Service Inc | 6936.1 | -0.38 | 0 |
EHTH | eHealth Inc | 0.51 | 0.6 | 0.43 |
FANH | Fanhua Inc | 0.35 | -0.35 | -0.28 |
FGF | Fundamental Global, Inc | 0.17 | -0.08 | -0.07 |
GVFG | Gerova Financial Group Ltd | 0.56 | 1 | 0.71 |
HUIZ | Huize Holding Ltd | 0.31 | 0.51 | 0.41 |
WTG.L | Watchstone Group PLC | 0 | 0.13 | 0.13 |
Low | High | |
Unlevered beta | 0.12 | 0.42 |
Relevered beta | 0.06 | 0.25 |
Adjusted relevered beta | 0.37 | 0.5 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for NXG.V:
cost_of_equity (6.80%) = risk_free_rate (4.15%) + equity_risk_premium (5.60%) * adjusted_beta (0.37) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.